Pathophysiology of motor response complications in Parkinson's disease: Hypotheses on the why, where, and what
- 26 January 2000
- journal article
- editorial
- Published by Wiley in Movement Disorders
Abstract
No abstract availableThis publication has 54 references indexed in Scilit:
- Parkinson Disease, the Effect of Levodopa, and the ELLDOPA TrialArchives of Neurology, 1999
- Levodopa therapyNeurology, 1998
- The response to levodopa in parkinson's disease: Imposing pharmacological law and orderAnnals of Neurology, 1996
- Dyskinesia and wearing‐off following dopamine D1 agonist treatment in drug‐naive 1‐Methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐lesioned primatesMovement Disorders, 1996
- Management of parkinsonism and treatment of associated complicationsCurrent Opinion in Neurology, 1995
- Chairmanʼs ConclusionClinical Neuropharmacology, 1994
- Continuous and intermittent levodopa differentially affect rotation induced by D-1 and D-2 dopamine agonistsEuropean Journal of Pharmacology, 1989
- Motor fluctuations in Parkinson's disease: Central pathophysiological mechanisms, part IIAnnals of Neurology, 1988
- Nonaminergic striatal neurons convert exogenous l‐dopa to dopamine in parkinsonismAnnals of Neurology, 1980
- Hyperactivity of Remaining Dopaminergic Neurones after Partial Destruction of the Nigro-striatal Dopaminergic System in the RatNature New Biology, 1973